openPR Logo
Press release

Global Fetal & Neonatal Care Equipment Market to grow at a CAGR of 8.33% to reach USD 15,616.87 million by 2032, Evaluates DelveInsight

11-11-2025 06:48 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Fetal & Neonatal Care Equipment Market to grow at a CAGR

According to DelveInsight's analysis, The global demand for fetal and neonatal care equipment is largely driven by the rising incidence of preterm births. Additionally, the growing prevalence of congenital anomalies and birth defects, coupled with ongoing technological advancements, is supporting market growth. Continuous product innovations and frequent launches by key players are also contributing to the expansion of the market. These factors are expected to play a crucial role in driving the positive growth of the fetal and neonatal care equipment market during the forecast period from 2025 to 2032.

DelveInsight's "Fetal & Neonatal Care Equipment Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Fetal & Neonatal Care Equipment companies actively working in the market.

To know more about why North America is leading the market growth in the Fetal & Neonatal Care Equipment market, get a snapshot of the report Fetal & Neonatal Care Equipment Market Trends
https://www.delveinsight.com/sample-request/fetal-and-neonatal-care-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Fetal & Neonatal Care Equipment Overview
Fetal & Neonatal Care Equipment refers to medical devices and tools used to monitor, support, and treat the health of fetuses (unborn babies) and neonates (newborns, especially preterm or ill infants). These equipment are essential in ensuring proper growth, detecting complications early, and providing critical care in delivery rooms, neonatal intensive care units (NICUs), and obstetric settings.

DelveInsight Analysis: The fetal and neonatal care equipment market size was valued at USD 8,276.38 million in 2024 and is projected to grow at a CAGR of 8.33% between 2025 and 2032, reaching USD 15,616.87 million by 2032.

Fetal & Neonatal Care Equipment Market Insights
Geographically, North America is projected to lead the fetal and neonatal care equipment market in 2024, capturing the largest regional market share. This leadership is driven by factors such as the increasing incidence of preterm births, the growing prevalence of congenital anomalies, and the region's advanced healthcare infrastructure. Furthermore, continuous technological innovations from key industry players are expected to sustain and boost the growth of the fetal and neonatal care equipment market in North America.

To read more about the latest highlights related to Fetal & Neonatal Care Equipment, get a snapshot of the key highlights entailed in the Fetal & Neonatal Care Equipment Insights
https://www.delveinsight.com/report-store/fetal-and-neonatal-care-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Fetal & Neonatal Care Equipment Market Report
• In October 2024, Philips introduced the Philips Avent Connected Baby Monitor, featuring a mobile app designed to provide neonatal monitoring.
• In July 2024, Huntleigh, an Arjo company, announced the launch of the Smartsigns SC500 Series Vital Signs Monitor. This versatile, mains/battery-operated monitor features an 8-inch color display and offers a robust platform for monitoring vital signs, suitable for use with adult, pediatric, and neonatal patients.
• In May 2024, Masimo announced FDA clearance for StorkTM, a baby monitoring system designed for at-home use. The FDA-cleared, over-the-counter (OTC) version of Stork monitors critical vitals, including oxygen saturation level (SpO2), pulse rate (PR), and skin temperature. The system features visual and audible alarms to notify caregivers if the baby's SpO2 or PR readings fall outside of preset ranges, ensuring timely intervention and enhanced safety.
• Thus, owing to such developments in the market, rapid growth will be observed in the Fetal & Neonatal Care Equipment market during the forecast period

Key Players in the Fetal & Neonatal Care Equipment Market
Some of the key market players operating in the Fetal & Neonatal Care Equipment market include- Lonza, Pfizer Inc., Catalent, Inc., Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Recipharm AB, Evotec, Novo Nordisk A/S, Siegfried Holding AG, Enzene Biosciences Ltd., Forge Biologics, BeiGene LTD., FUJIFILM Holdings Corporation, TOYOBO CO., LTD., AJINOMOTO CO., INC., Biocon, Eurofins Scientific, and others.

Which MedTech key players in the Fetal & Neonatal Care Equipment market are set to emerge as the trendsetter explore @ Key Fetal & Neonatal Care Equipment Companies
https://www.delveinsight.com/sample-request/fetal-and-neonatal-care-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Fetal & Neonatal Care Equipment Market Landscape
Ultrasound remains a preferred diagnostic tool due to its ability to evaluate fetal well-being and maternal health with minimal invasiveness. Market demand is further driven by new product launches and regulatory approvals, which improve device functionality and accessibility.
For instance, in November 2023, Siemens Healthineers introduced the ACUSON Maple, an affordable, versatile ultrasound system that leverages machine learning to automatically calculate fetal age and weight, cutting measurement time by up to 24% and enabling faster, more precise assessments.
Similarly, in June 2024, Clarius Mobile Health received FDA clearance for its Clarius OB AI handheld ultrasound, which automates fetal biometry measurements to determine age, weight, and growth intervals, enhancing point-of-care fetal monitoring capabilities.

Scope of the Fetal & Neonatal Care Equipment Market Report
• Coverage: Global
• Study Period: 2022-2032
• Fetal & Neonatal Care Equipment Market Segmentation By Product Type: Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others
• Fetal & Neonatal Care Equipment Market Segmentation By End-User: Hospitals, Specialty Clinics, and Others
• Fetal & Neonatal Care Equipment Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Fetal & Neonatal Care Equipment Companies: Lonza, Pfizer Inc., Catalent, Inc., Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Recipharm AB, Evotec, Novo Nordisk A/S, Siegfried Holding AG, Enzene Biosciences Ltd., Forge Biologics, BeiGene LTD., FUJIFILM Holdings Corporation, TOYOBO CO., LTD., AJINOMOTO CO., INC., Biocon, Eurofins Scientific, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Fetal & Neonatal Care Equipment market will grow by 2032? Click to get a snapshot of the Fetal & Neonatal Care Equipment Market Analysis
https://www.delveinsight.com/sample-request/fetal-and-neonatal-care-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Fetal & Neonatal Care Equipment Market to grow at a CAGR of 8.33% to reach USD 15,616.87 million by 2032, Evaluates DelveInsight here

News-ID: 4264828 • Views:

More Releases from DelveInsight Business Research

Familial Chylomicronemia Syndrome Market to Expand Significantly by 2034, States DelveInsight Report
Familial Chylomicronemia Syndrome Market to Expand Significantly by 2034, States …
DelveInsight's "Familial Chylomicronemia Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Familial Chylomicronemia Syndrome, historical and forecasted epidemiology as well as the Familial Chylomicronemia Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Familial Chylomicronemia Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Familial Chylomicronemia Syndrome
Generalized Anxiety Disorder Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Generalized Anxiety Disorder Pipeline 2025: Therapies, MOA Insights, and Key Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 12+ key companies continuously working towards developing 15+ Generalized Anxiety Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Generalized Anxiety Disorder Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Generalized Anxiety
Primary Mitochondrial Myopathies Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight
Primary Mitochondrial Myopathies Pipeline 2025: MOA, ROA, FDA-Approved Drugs, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Mitochondrial Myopathies pipeline constitutes 4+ key companies continuously working towards developing 4+ Primary Mitochondrial Myopathies treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Primary Mitochondrial Myopathies Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Primary Mitochondrial
Chlamydia Infections Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight
Chlamydia Infections Pipeline 2025: Therapies Under Investigation, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chlamydia Infections pipeline constitutes 5+ key companies continuously working towards developing 5+ Chlamydia Infections treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Chlamydia Infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also

All 5 Releases


More Releases for Fetal

Global Fetal And Maternal Monitor Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Fetal And Maternal Monitor market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Growing awareness of maternal and fetal health, particularly in developing nations, is driving the market for
Fetal Monitoring: Top Companies Revenue Analysis
The Fetal Monitoring Market is expected to register a CAGR of 6.93% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Brochure @ https://www.theinsightpartners.com/sample/TIPMD00002260/?utm_source=OpenPR&utm_medium=10432 The List of Companies 1. NEOVENTA MEDICAL AB 2. NATUS MEDICAL INCORPORATED 3. SIEMENS HEALTHCARE 4. GENERAL ELECTRIC COMPANY 5. ANALOGIC CORPORATION 6. FUJIFILM SONOSITE 7. PHILIPS HEALTHCARE 8. OSI SYSTEMS, INC 9. MEDTRONIC PLC 10. GETINGE GROUP Fetal Monitoring Market Segmentation Product Product • Ultrasound Devices • Fetal Monitors • Telemetry
[Latest] Fetal Monitoring Systems Market : An Overview
The ""Fetal Monitoring Systems Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Fetal Monitoring Systems Market, 2024-2031 Verified Market Research's most recent report, ""Fetal Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,""
2022 Fetal Monitoring Market Analysis, Industry Demand, Size, Sales, Trends Oppo …
The report covers current market growths including market enlargement, partnerships & collaborations, mergers & acquisitions, and new product launches. Moreover, the study includes an absolute financial study, SWOT profile, business policies, newly launched products & services, and a business summary of the market players. This study stakeholders and new business entrants to understand the present market trends and convey new business tactics. It also outlines the strategies adopted by them
Fetal Monitoring Market Size to Reach Valuation of $4.25 Billion by 2027 | Elect …
Growth of the global fetal monitoring market is attributed to increase in incidences of stillbirths, multiple pregnancy, late maternal age, technological advancements, and increase in emphasis on continuous fetal monitoring. Furthermore, rise in investments by governments in healthcare system and hospitals are some of the factors that contribute to the growth of the market. The fetal monitoring market was valued at $2.93 billion in 2019 and is expected to reach $4.25
Fetal Monitoring Market
Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe